Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 7/20 | 0.52 |
| ▸ | CA12 | O43570 | 4/20 | 0.52 |
| ▸ | CA7 | P43166 | 2/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 5/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | CA9 | Q16790 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2988092 | 0.85 | KEAP1 (0.54) | KEAP1CA2CA12CA7CA14 | |
| SCHEMBL138364 | 0.80 | CA2 (0.64) | KEAP1CA2CA12CA7CA14 | |
| SCHEMBL19042364 | 0.77 | CA2 (0.57) | KEAP1CA2CA12CA7CA14 | |
| SCHEMBL12256400 | 0.77 | CA12 (0.57) | KEAP1CA2CA12CA7CA14 | |
| SCHEMBL19042371 | 0.75 | CA2 (0.61) | KEAP1CA2CA12CA7CA14 | |
| SCHEMBL13266257 | 0.74 | CA2 (0.42) | KEAP1CA2CA1KMT2AALDH1A1 | |
| SCHEMBL11348996 | 0.73 | CA2 (0.68) | KEAP1CA2CA12CA7CA14 | |
| SCHEMBL13900224 | 0.73 | CA12 (0.61) | KEAP1CA2CA12CA7CA14 | |
| SCHEMBL2991758 | 0.72 | CA2 (0.41) | KEAP1CA2CA1KMT2AALDH1A1 | |
| SCHEMBL407414 | 0.72 | KEAP1 (1.00) | KEAP1CA2CA12CA7CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2084166-B1 | PREPARATION PROCESS OF AROMATIC SULFONYLIMIDES | INST NAT POLYTECHNIQUE DE GRENOBLE (FR) | 2017-11-22 | — | — | EP | disclosed |
| US-8853448-B2 | Aromatic sulfonylimides, preparation thereof and use thereof as electrolyte | INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) | 2014-10-07 | — | — | US | disclosed |
| US-8853448-B2 | Aromatic sulfonylimides, preparation thereof and use thereof as electrolyte | INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) | 2014-10-07 | — | — | US | disclosed |
| US-20100174113-A1 | AROMATIC SULPHONYLIMIDES, PREPARATION THEREOF AND USE THEREOF AS ELECTROLYTE | INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) | 2010-07-08 | — | — | US | disclosed |
| US-20100174113-A1 | AROMATIC SULPHONYLIMIDES, PREPARATION THEREOF AND USE THEREOF AS ELECTROLYTE | INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) | 2010-07-08 | — | — | US | disclosed |
| EP-2084166-A1 | AROMATIC SULPHONYLIMIDES, PREPARATION THEREOF AND USE THEREOF AS ELECTROLYTE | Institut National Polytechnique de Grenoble (FR) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008009814-A1 | AROMATIC SULPHONYLIMIDES, PREPARATION THEREOF AND USE THEREOF AS ELECTROLYTE. | INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) | 2008-01-24 | — | — | WO | disclosed |
| WO-2008009814-A1 | AROMATIC SULPHONYLIMIDES, PREPARATION THEREOF AND USE THEREOF AS ELECTROLYTE. | INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) | 2008-01-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100174113-A1 | AROMATIC SULPHONYLIMIDES, PREPARATION THEREOF AND USE THEREOF AS ELECTROLYTE | AFF2, ARSA, FGFR2 | KEAP1 2846/4885CA2 173/4885CA12 1001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.